- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anthem BioSciences Ltd (ANTH)
Anthem BioSciences Ltd stock price live, this page displays NSE ANTH stock exchange data. View the ANTH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Anthem BioSciences Ltd real time stock price chart below.
What Is the Anthem BioSciences Ltd Stock Price Today?
The Anthem BioSciences Ltd stock price today is 777.00.
What Is the Stock Symbol for Anthem BioSciences Ltd?
The stock symbol for Anthem BioSciences Ltd is "ANTH."
What Stock Exchange Does Anthem BioSciences Ltd Trade On?
Anthem BioSciences Ltd is listed and trades on the NSE stock exchange.
Is Anthem BioSciences Ltd a Good Stock to Buy?
Determining whether Anthem BioSciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANTH quote. (ISIN: INE0CZ201020)
What Is the Anthem BioSciences Ltd Stock Price Today?
The Anthem BioSciences Ltd stock price today is 777.00.
What Is the Stock Symbol for Anthem BioSciences Ltd?
The stock symbol for Anthem BioSciences Ltd is "ANTH."
What Stock Exchange Does Anthem BioSciences Ltd Trade On?
Anthem BioSciences Ltd is listed and trades on the NSE stock exchange.
Is Anthem BioSciences Ltd a Good Stock to Buy?
Determining whether Anthem BioSciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANTH quote. (ISIN: INE0CZ201020)
777.00
+18.05(+2.38%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
754.60
782.95
52 wk Range
579.15
873.50
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
754.60782.95
52 wk Range
579.15873.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.26%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.26%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ANTH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
879.43
Upside
+13.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 879.43
(+13.18% Upside)
Earnings
Latest Release
Jun 03, 2026
EPS / Forecast
3.40 / 2.20
Revenue / Forecast
6.11B / 4.83B
Compare ANTH to Peers and Sector
Metrics to compare | ANTH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANTHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 73.9x | 43.6x | −0.4x | |
PEG Ratio | 2.49 | 0.24 | 0.00 | |
Price/Book | 14.4x | 3.6x | 2.6x | |
Price / LTM Sales | 20.6x | 6.1x | 3.0x | |
Upside (Analyst Target) | 12.0% | 12.3% | 53.5% | |
Fair Value Upside | Unlock | 5.3% | 9.0% | Unlock |
Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial manufacturing of RNA-based therapies, antibody-drug conjugates, peptides and oligonucleotides, lipids, biologics and biotherapeutics, fermentation, biosynthesis and biotransformation, and flow chemistry. It also manufactures and sells complex specialized fermentation-based active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2; microbial and mammalian biosimilars; probiotics, such as bacillus species, lactobacillus species, bifidobacterium species, streptococcus species and saccharomyces boulardii; enzymes; peptides, including semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide; nutritional actives, vitamin analogues, and APIs. The company was incorporated in 2006 and is based in Bengaluru, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Anthem BioSciences (ANTH) Stock Price Today?
The Anthem BioSciences stock price today is 777.00 INR.
What Stock Exchange Does Anthem BioSciences Trade On?
Anthem BioSciences is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Anthem BioSciences?
The stock symbol for Anthem BioSciences is "ANTH."
Does Anthem BioSciences Pay Dividends? What’s The Current Dividend Yield?
The Anthem BioSciences dividend yield is 0.26%.
What Is the Anthem BioSciences Market Cap?
As of today, Anthem BioSciences market cap is 437.60B INR.
What Is Anthem BioSciences's Earnings Per Share (TTM)?
The Anthem BioSciences EPS (TTM) is 10.43.
When Is the Next Anthem BioSciences Earnings Date?
Anthem BioSciences will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is ANTH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Anthem BioSciences Stock Split?
Anthem BioSciences has split 0 times.
How Many Employees Does Anthem BioSciences Have?
Anthem BioSciences has 2282 employees.
What is the current trading status of Anthem BioSciences (ANTH)?
As of Jul 19, 2026, Anthem BioSciences (ANTH) is trading at a price of 777.00 INR, with a previous close of 758.95 INR. The stock has fluctuated within a day range of 754.60 INR to 782.95 INR, while its 52-week range spans from 579.15 INR to 873.50 INR.
What Is Anthem BioSciences (ANTH) Price Target According to Analysts?
The average 12-month price target for Anthem BioSciences is 879.43 INR, with a high estimate of 956 INR and a low estimate of 830 INR. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +13.18% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.